{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,8]],"date-time":"2023-10-08T20:14:01Z","timestamp":1696796041281},"reference-count":0,"publisher":"Oxford University Press (OUP)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JNCI Journal of the National Cancer Institute"],"published-print":{"date-parts":[[2004,6,16]]},"DOI":"10.1093\/jnci\/96.12.903","type":"journal-article","created":{"date-parts":[[2004,6,16]],"date-time":"2004-06-16T03:28:03Z","timestamp":1087356483000},"page":"903-904","source":"Crossref","is-referenced-by-count":3,"title":["Next Generation of Targeted Radiotherapy Drugs Emerging From the Clinical Pipeline"],"prefix":"10.1093","volume":"96","author":[{"given":"B.","family":"Goldman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2004,6,15]]},"container-title":["JNCI Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jnci\/article-pdf\/96\/12\/903\/9835348\/903.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T11:21:54Z","timestamp":1503573714000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article-lookup\/doi\/10.1093\/jnci\/96.12.903"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6,15]]},"references-count":0,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2004,6,15]]},"published-print":{"date-parts":[[2004,6,16]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/96.12.903","relation":{},"ISSN":["0027-8874","1460-2105"],"issn-type":[{"value":"0027-8874","type":"print"},{"value":"1460-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,6,15]]}}}